Press Releases

22 February 2018

Akston Biosciences Awarded Phase II SBIR by NIH/NIDDK

16 March 2017

Helmsley Charitable Trust and Akston Biosciences Corporation Announce Partnership to Advance Novel Technology to Treat Type 1 Diabetes

12 January 2015

Ultra-long-acting recombinant insulin for the treatment of diabetes mellitus in dogs